+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
H1N1 Vaccines Market by Product Type (Inactivated Vaccine, Live Attenuated Vaccine), Technology (Cell Based, Egg Based, Recombinant), End User, Distribution Channel, Dosage Form, Age Group - Global Forecast 2025-2030- Product Image
H1N1 Vaccines Market by Product Type (Inactivated Vaccine, Live Attenuated Vaccine), Technology (Cell Based, Egg Based, Recombinant), End User, Distribution Channel, Dosage Form, Age Group - Global Forecast 2025-2030- Product Image
Sale

H1N1 Vaccines Market by Product Type (Inactivated Vaccine, Live Attenuated Vaccine), Technology (Cell Based, Egg Based, Recombinant), End User, Distribution Channel, Dosage Form, Age Group - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904545
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Executive decision-makers navigating the evolving immunization sector require up-to-date, actionable intelligence on the H1N1 vaccines market to remain competitive. This overview distills essential insights challenging conventional strategies, highlighting actionable opportunities across complex global value chains.

Market Snapshot: H1N1 Vaccines Market Growth

The H1N1 Vaccines Market grew from USD 13.45 billion in 2024 to USD 18.42 billion in 2025. It is expected to continue growing at a CAGR of 35.61%, reaching USD 83.70 billion by 2030. This rapid expansion reflects rising demand, new production paradigms, and adaptive strategies to strengthen public health infrastructure.

Scope & Segmentation: In-Depth Analysis of H1N1 Vaccine Ecosystem

This report provides a comprehensive view across product types, technologies, user profiles, distribution models, and regions. The breadth of segmentation supports senior leaders in identifying opportunities and potential risks within the H1N1 vaccines market.

  • Product Types: Inactivated vaccine (including cell-based, egg-based, recombinant), live attenuated vaccine (egg-based only)
  • Technologies: Cell-based, egg-based, and recombinant production methodologies
  • End Users: Clinics, hospitals, public health centers
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies
  • Dosage Forms: Multi-dose vials, pre-filled syringes
  • Age Groups: Adults, children, seniors
  • Geographic Regions:
    • Americas: United States (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Companies Evaluated: Sanofi Pasteur SA, GlaxoSmithKline plc, CSL Seqirus Pty Ltd, Novartis AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Moderna, Inc., Bharat Biotech International Limited, Bavarian Nordic A/S, Panacea Biotec Limited

Key Takeaways for H1N1 Vaccines Market Stakeholders

  • Technological advances in cell-based and recombinant manufacturing are reducing production lead times, improving scalability for rapid pandemic response.
  • Adaptive regulatory approaches streamline approval of new vaccine formulations and enable market entry without compromising patient safety or efficacy standards.
  • Strategic partnerships and facility upgrades are broadening manufacturing capacity, supporting supply to diverse geographies and marginal populations.
  • Segmentation by end user and distribution channels helps tailor product formats and delivery logistics for clinic, hospital, and public health center requirements.
  • Multi-level distribution strategies optimize vaccine outreach, supporting equity in immunization coverage across age groups and regions.
  • Rising private-public collaboration underpins supply chain resilience, ensuring availability during policy or market disruptions.

Tariff Impact: Navigating Regulatory and Cost Challenges

Revised United States tariffs on critical inputs have increased raw material expenses and driven realignment of sourcing and manufacturing strategies. Some manufacturers are relocating capacity or investing in domestic production to reduce future tariff exposure. Temporary duty exclusions and strategic stockpiling have stabilized short-term supply, but these dynamics necessitate ongoing vigilance for supply chain efficiency and cost control.

Methodology & Data Sources

This analysis draws on secondary research, expert interviews, peer-reviewed literature, regulatory documents, and proprietary reports. Stakeholders from across the value chain, including public health bodies and logistics partners, informed qualitative and quantitative findings, ensuring market insights are comprehensive and reliable.

Why This Report Matters: Applications for Decision-Makers

  • Uncovers actionable trends in vaccine production, technology adoption, and supplier collaborations.
  • Enables leaders to identify priorities for investment, capacity building, and supply chain resilience.
  • Supports effective planning to address evolving regulatory environments and demographic shifts in immunization demand.

Conclusion

This report delivers critical insights for senior decision-makers shaping the future of the H1N1 vaccines market. By leveraging these findings, stakeholders can drive effective, resilient, and timely vaccination strategies amidst ongoing public health change.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of mRNA-based delivery platforms to accelerate H1N1 vaccine production timelines
5.2. Advancements in universal influenza vaccine research targeting conserved H1N1 epitopes across strains
5.3. Implementation of thermostable H1N1 vaccine formulations to improve cold chain independence
5.4. Expansion of strategic partnerships between biotech firms and government agencies for H1N1 pandemic preparedness
5.5. Development of needle-free intranasal H1N1 vaccines to enhance patient compliance and coverage
5.6. Integration of AI-driven surveillance data to forecast H1N1 outbreak hotspots and guide vaccine distribution
5.7. Increasing investments in cell-based H1N1 vaccine manufacturing capacity to meet surge demand
5.8. Regulatory streamlining for emergency use authorization of H1N1 vaccines during outbreak surges
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. H1N1 Vaccines Market, by Product Type
8.1. Introduction
8.2. Inactivated Vaccine
8.2.1. Cell Based
8.2.2. Egg Based
8.2.3. Recombinant
8.3. Live Attenuated Vaccine
8.3.1. Egg Based
9. H1N1 Vaccines Market, by Technology
9.1. Introduction
9.2. Cell Based
9.3. Egg Based
9.4. Recombinant
10. H1N1 Vaccines Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Hospitals
10.4. Public Health Centers
11. H1N1 Vaccines Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. H1N1 Vaccines Market, by Dosage Form
12.1. Introduction
12.2. Multi-Dose Vials
12.3. Pre-Filled Syringes
13. H1N1 Vaccines Market, by Age Group
13.1. Introduction
13.2. Adults
13.3. Children
13.4. Seniors
14. Americas H1N1 Vaccines Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa H1N1 Vaccines Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific H1N1 Vaccines Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Sanofi Pasteur SA
17.3.2. GlaxoSmithKline plc
17.3.3. CSL Seqirus Pty Ltd
17.3.4. Novartis AG
17.3.5. Pfizer Inc.
17.3.6. Takeda Pharmaceutical Company Limited
17.3.7. Moderna, Inc.
17.3.8. Bharat Biotech International Limited
17.3.9. Bavarian Nordic A/S
17.3.10. Panacea Biotec Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. H1N1 VACCINES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL H1N1 VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL H1N1 VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL H1N1 VACCINES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL H1N1 VACCINES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES H1N1 VACCINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES H1N1 VACCINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. H1N1 VACCINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. H1N1 VACCINES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. H1N1 VACCINES MARKET: RESEARCHAI
FIGURE 28. H1N1 VACCINES MARKET: RESEARCHSTATISTICS
FIGURE 29. H1N1 VACCINES MARKET: RESEARCHCONTACTS
FIGURE 30. H1N1 VACCINES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. H1N1 VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL H1N1 VACCINES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL H1N1 VACCINES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL H1N1 VACCINES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL H1N1 VACCINES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL H1N1 VACCINES MARKET SIZE, BY CELL BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL H1N1 VACCINES MARKET SIZE, BY CELL BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL H1N1 VACCINES MARKET SIZE, BY EGG BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL H1N1 VACCINES MARKET SIZE, BY EGG BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL H1N1 VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL H1N1 VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL H1N1 VACCINES MARKET SIZE, BY EGG BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL H1N1 VACCINES MARKET SIZE, BY EGG BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL H1N1 VACCINES MARKET SIZE, BY CELL BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL H1N1 VACCINES MARKET SIZE, BY CELL BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL H1N1 VACCINES MARKET SIZE, BY EGG BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL H1N1 VACCINES MARKET SIZE, BY EGG BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL H1N1 VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL H1N1 VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL H1N1 VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL H1N1 VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL H1N1 VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL H1N1 VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL H1N1 VACCINES MARKET SIZE, BY PUBLIC HEALTH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL H1N1 VACCINES MARKET SIZE, BY PUBLIC HEALTH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL H1N1 VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL H1N1 VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL H1N1 VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL H1N1 VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL H1N1 VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL H1N1 VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL H1N1 VACCINES MARKET SIZE, BY MULTI-DOSE VIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL H1N1 VACCINES MARKET SIZE, BY MULTI-DOSE VIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL H1N1 VACCINES MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL H1N1 VACCINES MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL H1N1 VACCINES MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL H1N1 VACCINES MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL H1N1 VACCINES MARKET SIZE, BY CHILDREN, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL H1N1 VACCINES MARKET SIZE, BY CHILDREN, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL H1N1 VACCINES MARKET SIZE, BY SENIORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL H1N1 VACCINES MARKET SIZE, BY SENIORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES H1N1 VACCINES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES H1N1 VACCINES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. CANADA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. CANADA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 104. CANADA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 105. CANADA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 106. CANADA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 107. CANADA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 108. CANADA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 109. CANADA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. CANADA H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. CANADA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. CANADA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. CANADA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 114. CANADA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 115. CANADA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 116. CANADA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 117. MEXICO H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. MEXICO H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. MEXICO H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 121. MEXICO H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 122. MEXICO H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 123. MEXICO H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 124. MEXICO H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 125. MEXICO H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. MEXICO H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. MEXICO H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. MEXICO H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. MEXICO H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 130. MEXICO H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 131. MEXICO H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 132. MEXICO H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 199. GERMANY H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. GERMANY H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. GERMANY H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 202. GERMANY H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 203. GERMANY H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 204. GERMANY H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 205. GERMANY H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 206. GERMANY H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 207. GERMANY H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. GERMANY H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. GERMANY H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. GERMANY H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. GERMANY H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 212. GERMANY H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 213. GERMANY H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 214. GERMANY H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 215. FRANCE H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. FRANCE H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. FRANCE H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 218. FRANCE H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 219. FRANCE H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 220. FRANCE H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 221. FRANCE H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 222. FRANCE H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 223. FRANCE H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. FRANCE H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. FRANCE H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. FRANCE H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. FRANCE H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 228. FRANCE H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 229. FRANCE H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 230. FRANCE H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 247. ITALY H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. ITALY H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. ITALY H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 250. ITALY H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 251. ITALY H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 252. ITALY H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 253. ITALY H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. ITALY H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. ITALY H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. ITALY H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. ITALY H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. ITALY H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. ITALY H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 260. ITALY H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 261. ITALY H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 262. ITALY H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 263. SPAIN H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. SPAIN H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. SPAIN H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 266. SPAIN H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 267. SPAIN H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 268. SPAIN H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 269. SPAIN H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 270. SPAIN H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 271. SPAIN H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. SPAIN H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. SPAIN H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. SPAIN H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. SPAIN H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 276. SPAIN H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 277. SPAIN H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 278. SPAIN H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 327. DENMARK H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 328. DENMARK H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 329. DENMARK H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 330. DENMARK H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 331. DENMARK H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 332. DENMARK H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 333. DENMARK H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 334. DENMARK H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 335. DENMARK H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. DENMARK H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. DENMARK H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 338. DENMARK H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 339. DENMARK H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 340. DENMARK H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 341. DENMARK H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 342. DENMARK H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 343. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 344. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 345. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 346. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 347. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2024 (USD MILLION)
TABLE 348. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2025-2030 (USD MILLION)
TABLE 349. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 350. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 351. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 352. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 353. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 354. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 355. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 356. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 357. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 358.

Samples

Loading
LOADING...

Companies Mentioned

  • Sanofi Pasteur SA
  • GlaxoSmithKline plc
  • CSL Seqirus Pty Ltd
  • Novartis AG
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Moderna, Inc.
  • Bharat Biotech International Limited
  • Bavarian Nordic A/S
  • Panacea Biotec Limited

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 18.42 Billion
Forecasted Market Value ( USD ) by 2030 $ 83.7 Billion
Compound Annual Growth Rate35.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

H1N1 Vaccines - Global Strategic Business Report - Product Image

H1N1 Vaccines - Global Strategic Business Report

  • Report
  • 268 Pages
  • Global
From
H1N1 Vaccine Market Report 2025 - Product Image

H1N1 Vaccine Market Report 2025

  • Report
  • 200 Pages
  • Global
From
H1N1 Vaccines Market Report by Vaccine Type (Intramuscular, Intranasal, Intradermal), Market Type (Public, Private), and Region 2025-2033 - Product Image

H1N1 Vaccines Market Report by Vaccine Type (Intramuscular, Intranasal, Intradermal), Market Type (Public, Private), and Region 2025-2033

  • Report
  • 143 Pages
  • Global
From
H1N1 Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

H1N1 Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 186 Pages
  • Global
From
India Influenza Vaccine Market, Region, Competition, Forecast & Opportunities, 2020-2030F - Product Image

India Influenza Vaccine Market, Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • 85 Pages
  • India
From

About the H1N1 Vaccine Market

The H1N1 Vaccine is a vaccine developed to protect against the H1N1 strain of influenza, also known as swine flu. It is a type of inactivated vaccine, meaning it contains killed virus particles that are unable to cause infection. The vaccine is administered through injection and is recommended for people of all ages. It is especially important for those at high risk of complications from the virus, such as pregnant women, young children, and people with weakened immune systems. The H1N1 Vaccine market is a subset of the larger Vaccines market, which includes a wide range of products designed to protect against infectious diseases. Vaccines are an important tool in public health, as they can help reduce the spread of disease and protect vulnerable populations. Some companies in the H1N1 Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck, and Pfizer. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.